Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX

Ischemic Events Occur Early in Patients Undergoing Percutaneous Coronary Intervention and Are Reduced With Cangrelor: Findings From CHAMPION PHOENIX

BACKGROUND: Thrombotic events are reduced with cangrelor, an intravenous P2Y12 inhibitor. We sought to characterize the timing, number, and type of early events (within 2 hours of randomization) in CHAMPION PHOENIX (A Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subj...

Full description

Bibliographic Details
Main Authors: Bhatt, D.L (Author), Cavender, M.A (Author), CHAMPION PHOENIX Investigators* (Author), Deliargyris, E.N (Author), Gibson, C.M (Author), Hamm, C.W (Author), Harrington, R.A (Author), Leonardi, S. (Author), Lopes, R.D (Author), Mahaffey, K.W (Author), Prats, J. (Author), Price, M.J (Author), Steg, P.G (Author), Stone, G.W (Author), White, H.D (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
coronary artery disease
myocardial infarction
P2Y12 receptor antagonist
percutaneous coronary intervention
thrombosis
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items